Filing Flows › Novartis AG (NVS) › Recalls, complaints & regulation
Novartis AG (NVS): recalls, clinical trials and Federal Register
Novartis AG (NVS) beyond its filings: 1 recall in the last 12 months (8 in five years, 2 Class I); 5 Federal Register documents in a year; 367 active clinical trials.
Latest recalls
- 2026-08-19 · FDA drug · Diovan (valsartan) 160 mg, 90 tablets, Rx only, Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834, Distributed by: Novartis Pharmaceutic
- 2023-12-13 · FDA drug · SANDIMMUNE Oral Solution (cyclosporine oral solution, USP) 100 mg/mL, 50 mL bottle, Rx Only, Manufactured by: DELPHARM Huningue S.A.S., Huningue, France, Distri
- 2023-09-27 · FDA drug · SANDIMMUNE Oral Solution (cyclosporine oral solution, USP) 100 mg/mL, 50 mL bottle, Rx Only, Manufactured by: DELPHARM Huningue S.A.S., Huningue, France, Distr
- 2022-10-05 · FDA drug · Neoral soft gelatin capsules (cyclosporine capsules, USP) Modified, 25 mg, Rx Only, 30 Soft Gelatin Capsules per carton, Mfg by: Novartis Pharmaceuticals Corpor
- 2022-06-15 · FDA drug · Xiidra (lifitegrast ophthalmic solution) 5% PROFESSIONAL SAMPLE, packaged in a) 5 single-use containers (0.2 mL each vial) (NDC 54092-606-07) and b) 4 pouches x
- 2022-06-15 · FDA drug · Xiidra (lifitegrast ophthalmic solution) 5% PROFESSIONAL SAMPLE, packaged in a) 5 single-use containers (0.2 mL each vial) (NDC 0078-0911-95) and b) 4 pouches x
- 2022-06-15 · FDA drug · Xiidra (lifitegrast ophthalmic solution) 5%, packaged in a) 60 Single-Use Containers: 12 pouches x 5 single-use containers (0.2 mL each vial) (NDC 54092-606-01)
- 2022-06-15 · FDA drug · Xiidra (lifitegrast ophthalmic solution), packaged in a) 60 Single-Use Containers: 12 pouches x 5 single-use containers (0.2 mL each vial) (NDC 0078-0911-12) an
Novartis AG's latest quarter
Novartis AG, Q3 2026: revenue $14.5B (+4% year over year), operating margin 12.7%, net earnings $1.2B, operating cash flow $5.5B. The chart follows the revenue to costs, profit and cash.
Questions
Has Novartis AG had any recalls?
8 recalls on file over five years from the FDA, CPSC and NHTSA; 1 in the last 12 months.
How many clinical trials does Novartis AG have?
367 active studies on ClinicalTrials.gov, 90 in phase 3.
Updated Nov 9, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.